Temsirolimus combined with cisplatin or bevacizumab is active in osteosarcoma models

Emmy D.G. Fleuren, Yvonne M.H. Versleijen-Jonkers, Melissa H.S. Roeffen, Gerben M. Franssen, Uta E. Flucke, Peter J. Houghton, Wim J.G. Oyen, Otto C. Boerman, Winette T.A. Van Der Graaf

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Temsirolimus combined with cisplatin or bevacizumab is active in osteosarcoma models'. Together they form a unique fingerprint.

Medicine & Life Sciences